Huge triple-negative phyllodes breast cancer: a case report

被引:0
|
作者
Zheng, Zhouci [1 ]
Wu, Qiaolin [2 ]
Jin, Yixiang [1 ]
Jin, Wenxu [1 ]
Wang, Qingxuan [1 ]
Cai, Yefeng [1 ]
Chen, Endong [1 ]
Zhang, Xiaohua [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China
关键词
Phyllodes breast tumor; triple-negative breast cancer; core-needle biopsy; mastectomy; adjuvant therapy; SURGICAL-TREATMENT; TUMORS; STATISTICS; PROGNOSIS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Phyllodes breast tumor is a rare entity of breast cancer. Less than 1% of primary-breast-tumor patients will manifest phyllodes breast carcinoma. To date, no such case report has been published in Asia. A 59-year-old Chinese woman developed a huge mass in her left breast because of phyllodes tumor. The initial symptom of the patient was a solid mass fixed in her left breast. The postsurgical histopathologic results and immunohistochemical stains were consistent with a triple-negative phyllodes breast tumor. The patient received cytotoxic chemotherapy for one course and was recommended to undergo regular examinations every 3 months. Preoperative diagnosis of phyllodes breast tumor remains difficult given its atypical characteristics and unpredictable clinical behaviors at first presentation. Appropriate surgery is the cornerstone of treatment for those patients. Moreover, adjuvant chemotherapy is important in postsurgical treatment for triple-negative breast cancer patients.
引用
收藏
页码:14846 / 14850
页数:5
相关论文
共 50 条
  • [31] Morphotypes of the triple-negative breast cancer
    Koleckova, M.
    Kolar, Z.
    Ehrmann, J.
    Korinkova, G.
    Trojanec, R.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296
  • [32] Metastatic Triple-negative Breast Cancer
    Rakha, E. A.
    Chan, S.
    CLINICAL ONCOLOGY, 2011, 23 (09) : 587 - 600
  • [33] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [34] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204
  • [35] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [36] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [37] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [38] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [39] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [40] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269